Skip to main content
FinSpry Logo
FinSpry
AUTL logo
AUTL
(NASDAQ)
Autolus Therapeutics plc
$1.52-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Autolus Therapeutics plc (AUTL) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Autolus Therapeutics plc stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(10 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$8.08
↑ 431.58% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AUTL Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Emily Bodnar
HC Wainwright
BuyMaintains
$10.00
Kinjel Shah
Zacks Equity Research
BuyInitiates Coverage
-
Salim Syed
Mizuho
BuyMaintains
$10.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Matt Phipps
William Blair
BuyMaintains
-
Unknown Analyst
Goldman Sachs
BuyReiterates
$6.10 → $5.40
Unknown Analyst
Wells Fargo
BuyReiterates
$5.00
Emily Bodnar
HC Wainwright
BuyReiterates
$9.00 → $10.00
Gil Blum
Needham
BuyMaintains
$10.00
Emily Bodnar
HC Wainwright
BuyInitiates Coverage
$9.00 → $10.00

Frequently Asked Questions

What is the analyst consensus rating for AUTL?

The analyst consensus rating for AUTL is "Buy" based on 8 analyst recommendations.

What is the average price target for AUTL?

The average 12-month price target for AUTL is $8.08, representing an upside of 431.6% from the current price of $1.52.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.